The user is experiencing irritation from using PG with RU58841 and is seeking alternative solutions like K&B in the UK. They report redness, itchiness, and flaky skin from the current treatment.
Minoxidil may cause increased prolactin levels, leading to sideeffects like puffy nipples and chest tenderness. Users experienced these issues and considered stopping minoxidil while continuing or switching to other treatments like finasteride, microneedling, and supplements.
The user experienced chest soreness and mild gynecomastia after taking 1mg finasteride three times a week, which resolved after stopping the medication. They are considering trying a lower dose or topical finasteride to avoid sideeffects.
Topical dutasteride may have limited absorption due to its higher molecular mass compared to finasteride, potentially affecting its efficacy in suppressing DHT locally. Microneedling might enhance dutasteride absorption, possibly offering stronger local DHT suppression with fewer systemic effects.
RU58841 caused chest tightness, throat irritation, and headaches, leading the user to stop its use. The user plans to restart with a lower dose if symptoms fully disappear but remains cautious due to anxiety and sideeffects.
The user started using topical finasteride three days ago alongside minoxidil and is experiencing testicular pain, which they believe is a nocebo effect. They are anxious about the dosage and seeking advice on whether increasing the application frequency affects the overall dosage.
The conversation discusses the potential effectiveness and risks of using topical finasteride for hair loss, with considerations about using DMSO as a vehicle for application. Concerns are raised about DMSO's safety, absorption issues, and the systemic effects of topical finasteride.
The conversation discusses using a dermapen for microneedling to treat hair loss, with specific mention of using Minoxidil, Finasteride, Dutasteride, RU58841, KX-826, and other topicals. The user experienced sideeffects like palpitations and itching after microneedling and applying these treatments.
RU58841 stopped scalp itching for the user, providing relief from persistent itchiness associated with hair loss. Some users reported sideeffects like chest pain, while others found relief with different treatments like mometasone.
The user experienced genital itching while using finasteride and noticed a yellow bump, which improved with clotrimazole, but the itching persists. The discussion focuses on sideeffects of finasteride.
Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.
The conversation is about using topical finasteride for hair loss and concerns about its application, sideeffects, and practicality. Users suggest switching to oral finasteride for convenience, despite potential sideeffects.
A user's experience with hair loss treatments, specifically finasteride/dutasteride, and the potential for nocebo effects to influence side-effects. They caution others against focusing too much on possible side-effects when using these drugs, as they are generally safe and effective.
Topical minoxidil can cause increased body hair due to systemic absorption, varying by individual skin sensitivity. The user seeks experiences and solutions to prevent this sideeffect.
The user is using topical dutasteride, finasteride, minoxidil, and tretinoin but seeing no results or sideeffects. They also microneedle every two weeks but experience little bleeding, questioning if a thick scalp is preventing treatment effectiveness.
A user is considering switching from oral to topical treatments for hair loss due to sideeffects like watery semen and erectile dysfunction. They are currently using oral finasteride and minoxidil and are concerned about potential sexual sideeffects with topical use.
The conversation is about finding a safe carrier for topical antiandrogens like finasteride, kx-826, RU58841, and dutasteride to minimize systemic absorption and sideeffects. The user experiences sideeffects from these treatments and is seeking advice on carriers that reduce these effects.
A user is considering mixing Stemoxydine, RU-58841, Alfatradiol, and Tretinoin into a single topical solution for hair loss. They are concerned about potential interactions that could reduce the effectiveness of these ingredients.
Grape seeds can cause an itchy scalp among other sideeffects. Users discussed their experiences and treatments like Minoxidil, finasteride, and RU58841.
The conversation is about adjusting the dosage of topical Finasteride to avoid sideeffects like chest pain and breast swelling. The user is considering reducing the concentration to 0.1% or trying microdosing with 0.01-0.025% for lower systemic effects.
The user tried pyrilutamide for hair loss and noticed reduced scalp itch and improved skin but stopped due to mild heart sensations. They plan to update after consistent use, noting improved sleep when applied at night.
A user experienced rapid hair loss and was prescribed Desonide cream for mild Alopecia. They are seeking feedback on its effectiveness and potential sideeffects.
The experiences of users who have used RU58841 to treat hair loss, including both positive and negative effects. Some sideeffects reported include chest pain, joint pain in the hands, tinnitus, and increased heartbeat.
The conversation discusses the use of topical finasteride from Hasson and Wong, with claims that none of their 800 users reported sideeffects. The user expresses skepticism about these claims and seeks others' experiences with the treatment.
Some people may not respond to topical minoxidil due to low SULT1A1 enzyme activity, but oral minoxidil can be effective. Tretinoin may enhance minoxidil's effectiveness, and some users prefer oral minoxidil despite sideeffects.
Topical finasteride results in plasma levels 100 times lower than oral finasteride, potentially reducing systemic sideeffects. Users report similar efficacy with fewer sideeffects, suggesting a preference for topical application.